Pregnancy and constipation drug: does prucalopride pose risks to unborn babies?
NCT ID NCT04869280
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This study follows pregnant women with chronic constipation who took the drug prucalopride and compares them to those who did not. Researchers track health outcomes for mothers and infants for one year after birth to see if the drug is linked to birth defects or other problems. No treatment is given; it is purely observational.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC IDIOPATHIC CONSTIPATION (CIC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California San Diego
La Jolla, California, 92093, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could tai chi soothe stubborn gut troubles?
- New study checks how much constipation drug gets into breast milk
- Can needles ease tummy troubles? new study tests electro-acupuncture for IBS-C
- New drug aims to ease chronic constipation in large trial
- Can virtual reality soothe IBS symptoms?
- Could a pill ease tummy troubles for kids with IBS-C?